Attendees listen to a session presentation at the 'Pharmaceutical-Bio AX Great Transformation Seminar' held on Nov. 17 at the auditorium of the Korea Pharmaceutical and Bio-Pharma Manufacturers Association in Seoul's Seocho district. [Photo: ITCEN CloIT]

ITCEN CloIT, an AI and cloud specialist, said on Thursday it will strengthen its push into the pharmaceuticals and biotech industry AI transformation (AX) market based on its enterprise AI agent management platform, AgentGo.

Earlier, ITCEN CloIT held the 'Pharmaceutical-Bio AX Great Transformation Seminar: Beyond Demos to Real Results' on Nov. 17 at the Korea Pharmaceutical and Bio-Pharma Manufacturers Association in Seoul's Seocho district. About 100 working-level staff from pharmaceutical and biotech companies attended. ITCEN CloIT shared practical issues companies face when adopting AI, measures to address them and strategies for applying AI agents suited to corporate environments.

ITCEN CloIT's strategy is to support building an AX environment that links companies' existing business systems with AI, taking into account industry characteristics where security and regulatory 대응 are important. It aims to move beyond pilot introductions to real use in operations and company-wide rollout.

The company said the pharmaceuticals and biotech industry must meet security and regulatory requirements while handling vast amounts of data and documents from research and development to production, quality control and licensing approvals.

Interest in adopting AI is high, but protecting sensitive information, linking AI to business systems, and verification and approval processes for AI outputs are cited as challenges to broader adoption by working-level teams.

AgentGo supports companies' use of AI agents while maintaining control over data, based on security and management features including sensitive information masking, blocking prompt injection, user-by-user access control and audit logs. AgentGo can be deployed flexibly in line with corporate security policies and IT environments, including on-premises and private or public clouds.

ITCEN CloIT plans to support AI adoption and work innovation at pharmaceutical and biotech companies based on AgentGo, including industry-specific AI use cases and technical capabilities. It also plans to expand AX business opportunities optimised for industry characteristics.

Keyword

#ITCEN CloIT #AgentGo #Korea Pharmaceutical and Bio-Pharma Manufacturers Association #AI transformation #Seoul
Copyright © DigitalToday. All rights reserved. Unauthorized reproduction and redistribution are prohibited.